The tendency of nanoparticles to clump together in solution"agglomeration"is of great interest because the size of the clusters plays an important role in the behavior of the materials. Toxicity, the persistence of the nanomaterials in the environment, their efficacy as biosensors and, for that matter, the accuracy of experiments to measure these factors, are all known to be affected by agglomeration and cluster size. Recent work* at the National Institute of Standards and Technology (NIST) offers a way to measure accurately both the distribution of cluster sizes in a sample and the characteristic light absorption for each size. The latter is important for the application of nanoparticles in biosensors.
A good example of the potential application of the work, says NIST biomedical engineer Justin Zook, is in the development of nanoparticle biosensors for ultrasensitive pregnancy tests. Gold nanoparticles can be coated with antibodies to a hormone** produced by an embryo shortly after conception. Multiple gold nanoparticles can bind to each hormone, forming clusters that have a different color from unclustered gold nanoparticles. But only certain size clusters are optimal for this measurement, so knowing how light absorbance changes with cluster size makes it easier to design the biosensors to result in just the right sized clusters.
The NIST team first prepared samples of gold nanoparticlesa nanomaterial widely used in biologyin a standard cell culture solution, using their previously developed technique for creating samples with a controlled distribution of sizes***. The particles are allowed to agglomerate in gradually growing clusters and the clumping process is "turned off" after varying lengths of time by adding a stabilizing agent that prevents further agglomeration.
They then used a technique called analytical ultracentrifugation (AUC) to simultaneously sort the clusters by size and measure their light absorption. The centri
|Contact: Michael E. Newman|
National Institute of Standards and Technology (NIST)